UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
NetEase
NTES
|
+$383M |
| 2 |
AbbVie
ABBV
|
+$262M |
| 3 |
VMW
VMware, Inc
VMW
|
+$183M |
| 4 |
Aptiv
APTV
|
+$175M |
| 5 |
T-Mobile US
TMUS
|
+$170M |
Top Sells
| 1 |
Alibaba
BABA
|
+$591M |
| 2 |
Microsoft
MSFT
|
+$567M |
| 3 |
Apple
AAPL
|
+$464M |
| 4 |
Amazon
AMZN
|
+$268M |
| 5 |
Abbott
ABT
|
+$266M |
Sector Composition
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Mersana Therapeutics
MRSN
$35.6M
| $1.22M | ﹤0.01% |
+2,085
| New | +$1.22M |
|
1677
Akebia Therapeutics
AKBA
$782M
| $1.21M | ﹤0.01% |
89,187
+10,058
| +13% | +$137K |
|
1678
Yext
YEXT
$1.07B
| $1.2M | ﹤0.01% |
72,472
-11,873
| -14% | -$197K |
|
1679
Sonos
SONO
$1.83B
| $1.2M | ﹤0.01% |
82,273
-422,735
| -84% | -$6.18M |
|
1680
Invesco Mortgage Capital
IVR
$502M
| $1.2M | ﹤0.01% |
32,105
+6,489
| +25% | +$243K |
|
1681
Comfort Systems
FIX
$26.6B
| $1.2M | ﹤0.01% |
29,409
-5,131
| -15% | -$209K |
|
1682
Palomar
PLMR
$3.13B
| $1.2M | ﹤0.01% |
13,958
+2,558
| +22% | +$219K |
|
|
ITCI
1683
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.2M | ﹤0.01% |
46,588
+45
| +0.1% | +$1.16K |
|
1684
Esperion Therapeutics
ESPR
$573M
| $1.19M | ﹤0.01% |
23,208
+3,904
| +20% | +$200K |
|
1685
Liberty Latin America Class C
LILAK
$1.53B
| $1.19M | ﹤0.01% |
133,359
-4,411
| -3% | -$39.2K |
|
|
AVYA
1686
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.18M | ﹤0.01% |
95,498
-8,840
| -8% | -$109K |
|
1687
Addus HomeCare
ADUS
$2.03B
| $1.18M | ﹤0.01% |
12,735
+923
| +8% | +$85.4K |
|
1688
Gentherm
THRM
$1.06B
| $1.17M | ﹤0.01% |
30,102
-2,848
| -9% | -$111K |
|
1689
Cerence
CRNC
$450M
| $1.17M | ﹤0.01% |
28,625
-31,127
| -52% | -$1.27M |
|
1690
ICF International
ICFI
$1.83B
| $1.17M | ﹤0.01% |
18,022
-1,016
| -5% | -$65.9K |
|
1691
MacroGenics
MGNX
$100M
| $1.16M | ﹤0.01% |
41,655
-600,094
| -94% | -$16.8M |
|
1692
Greif
GEF
$3.59B
| $1.16M | ﹤0.01% |
33,770
-563
| -2% | -$19.4K |
|
1693
Kulicke & Soffa
KLIC
$2.01B
| $1.16M | ﹤0.01% |
55,508
-1,234
| -2% | -$25.7K |
|
|
PRFT
1694
DELISTED
Perficient Inc
PRFT
| $1.15M | ﹤0.01% |
32,200
-559
| -2% | -$20K |
|
|
MINI
1695
DELISTED
Mobile Mini Inc
MINI
| $1.15M | ﹤0.01% |
38,950
-11,531
| -23% | -$340K |
|
1696
Cytokinetics
CYTK
$6.12B
| $1.14M | ﹤0.01% |
48,409
-10,952
| -18% | -$258K |
|
1697
McGrath RentCorp
MGRC
$3.01B
| $1.14M | ﹤0.01% |
21,048
-5,152
| -20% | -$278K |
|
|
GNMK
1698
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.13M | ﹤0.01% |
76,692
+9,252
| +14% | +$136K |
|
1699
HNI Corp
HNI
$2.07B
| $1.13M | ﹤0.01% |
36,806
-13,003
| -26% | -$398K |
|
1700
MaxLinear
MXL
$1.37B
| $1.13M | ﹤0.01% |
52,429
-10,403
| -17% | -$223K |
|